Research Strategic Plan David W. Niesel, PhD Chief Research Officer SVP and Dean GSBS

Research Strategic Plan Research Planning Task Force Mariano Garcia-Blanco, MD, PhD Chair, BMB Kenneth Ottenbacher, PhD Professor, Rehab. Sciences Douglas Tyler, MD Chair, Surgery Michael Laposata, MD, PhD Chair, Pathology Kathryn Cunningham, PhD Director, CAR Allan Brasier, MD Director, ITS Nisha Garg, PhD Professor M&I and Assoc. Dir. IHII Andrew McNees, PhD, MBA Director, Research Ops. And Logistics Toni D’Agostino, MA Assoc. VP, Research Administration David W. Niesel, PhD Chief Research Officer

Strategic Management Timeline Process and Deliverables Resource Summary and Prioritization Implementation Plan Performance Monitoring & Reporting OnFocus Strategic Plan Adoption Engage Participants Drivers of Research UTMB Research 2020 Development Draft Goals/Objectives Future Picture Adoption Goal Adoption Objective Refinement Tactical Plan Development Adoption Process Target Setting Future Picture Aug 15 Sept 16 June 15 Mar 16 Nov 16 Infrastructure Discipline KPI Inventory Infrastructure Research Portfolio Budgeting Process Center/Institute Assessment Performance Monitoring and Reporting for FY16 and Preliminary FY17/Beyond Design and Recommend Assessment

Objectives Selected Optimize Clinical Research Infrastructure Expand imaging capabilities and capacity in support of all research areas Expand interdisciplinary research activity in Infection and Immunology Coordinate selective expansion of informatics development across and throughout research enterprise Expand interdisciplinary research activity in Neurodysfuntion Expand interdisciplinary research activity in Physical Medicine and Rehabilitation Expand interdisciplinary research activity in Pulmonary and Cardiovascular Increase Vaccine Development and Drug discovery activity

Top 5 Priority Objectives Resource Requirements Capital FY17 Capital FY18 One Time FY17 One Time FY18 Ongoing FY17 Ongoing FY18 New Faculty New Staff Optimize Clinical Research Infrastructure   Increase Vaccine development and Drug discovery activity by xx% annually through 4FQ17 $ 25 $ 10 $ 477 $ 727 3.00 Coordinate selective expansion of informatics development across and throughout research enterprise $ 200 $ 500 $ 145 $ 1,120 $ 346 $ 871 3.20 Expand interdisciplinary research activity in Infection and Immunology by 4FQ17 $ 250 $ 855 $ 655 2.00 0.50 Expand interdisciplinary research activity in Neurodysfuntion by 4FQ17 $ 4,200 $ 2,700 $ 5,000 $ 1,800 $ 2,350 Grand Total $ 4,925 $ 3,450 $ 6,010 $ 1,785 $ 3,123 $ 4,448 8.70

Why Neurodysfunction? Build on existing strengths Neuroinfection Addiction Pain Traumatic Brain Injury Rehabilitation science Alzheimer’s / Cognitive dysfunction Alignment with Clinical strategic plan to expand neurosciences Ongoing recruitment of new faculty Neuroscience CAR addiction psychiatrist Thursday, October 13, 2016 Many new projects explore human brain activity. The National Institutes of Health announced its third round of grants to support the goals of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, bringing NIH’s total fiscal year 2016 investment to just over $150 million.

Convergence around Investments in Neuroscience National Neuroscience research is a high Priority for NIH NIH Brain Initiative (UTS is 1 of 7 universities/systems as partners) Alzheimer’s Initiative ($638M) State UT Brain Program Chancellors Quantum Leap - Brain Health UTS Neuroscience and Neurotechnology Research Institute formed Neuroscience Council (2013)

Neurodysfunction Tactics Resource Requirements Objective / Tactic / Sub-Tactic Capital FY17 Capital FY18 One Time FY17 One Time FY18 Ongoing FY17 Ongoing FY18 New Faculty New Staff Expand interdisciplinary research activity in Neurodysfuntion by 4FQ17   Recruit PI/Co PI Expert(s) (One Time Expense identified for FY17 is already included in negotiated Start-up commitments) $ 200 $ 5,000 $ 100 Develop economically feasible models to engage physicians $ 300 $ 600 Focus on neurologic dysfunction samples $ 1,500 $ 500 Create specific seed grant program Purchase Neuroimaging equipment (fMRI) $ 2,500 2.00 Create "Research Marketing" catalog of fundable research strengths $ 50 Grand Total $ 4,200 $ 2,700 $ 5,000 $ - $ 1,800 $ 2,350 -

Where do we go from here? Executive Leadership Group (Institutional Planning) Overview of the plan, priorities and recommendations Seek partial funding for FY17 and build priorities into FY18 Capital and Operating budgets Productivity Enhancement (80% of costs are in people) Complete Centers and Institutes evaluation with recommendations for consolidation and redeployment of resources Focused philanthropy Evaluation of faculty research funding coverage expectations Documentation and establishment of an acceptable threshold for unfunded research (12% – 35% nationally)